[1]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67:7-30. [2]Chen WQ, Zheng RS, Zhang SW, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66:115-132. [3]Cervantes A, Roda D, Tarazona N, et al. Current questions for the treatment of advanced gastric cancer[J]. Cancer Treat Rev, 2013, 39(1):60-67. [4]王思萌, 高柳村, 帖君, 等. Cetuximab抑制胃癌SGC7901/ADR细胞的增殖并增加其化疗敏感性[J]. 现代生物医学进展, 2013, 13(12):2253-2256. [5]Kühl SJ, Kühl M. On the role of Wnt/β-catenin signaling in stem cells[J]. Biochim Biophys Acta, 2013, 1830(2):2297-2306. [6] Katoh M. WNT/PCP signaling pathway and human cancer(review)[J]. Oncol Rep, 2005, 14(6):1583-1588. [7]Clevers H, Nusse R. Wnt/β-catenin signaling and disease[J]. Cell, 2012, 149(6):1192-1205. [8]Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer[J]. Nat Rev Cancer, 2008, 8(5):387-398. [9]Long A, Giroux V, Whelan KA, et al. WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma[J]. Carcinogenesis, 2015, 36(5):598-606. [10]Hsu RJ, Ho JY, Cha TL, et al. WNT10A plays an oncogenic Role in Renal Cell Carcinoma by activation WNT/β-catenin pathway[J]. PLoS One, 2001, 7(10):e47649. [11]Kirikoshi H, Sekihara H, Katoh M. Up-regulation of Wntl0A by tumor necrosis factor alpha and Helicobacter pylori in gastric cancer[J]. Int J Oncol, 2001, 19(3):533-536. [12]Kirikoshi H, Inoue S, Sekihara H, et al. Expression of WNT10A in human cancer[J]. Int J Oncol, 2001, 19:997-1001. [13]Kirikoshi H, Sekihara H, Katoh M. WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly coexpressed in SW480 cells[J]. Biochem Bioph Res Co, 2001, 283:798-805. [14]Hanahan D, Weinberg RA. Hallmarks of Cancer:The next generation[J]. Cell, 2011, 144(5):646-674. [15]Delannay D, Cortay V, Patti D, et a1. Mimtic spindle asymmetry:a Wnt/PCP regulated mechanism generating asymmetrical division in cortical precursors[J]. Cell Rep, 2014, 6(2):400-414. [16]Hsieh AL, Dang CV. MYC, Metabolic Synthetic Lethality, and Cancer[J]. Recent Results Cancer Res, 2016, 207:73-91. [17]Tarrado-Castellarnau M, de Atauri P, Cascante M. Oncogenic regulation of tumor metabolic reprogramming[J]. Oncotarget, 2016, 7(38):62726-62753. |